Sabra Health Care REIT (NASDAQ:SBRA - Get Rating) will issue its quarterly earnings data after the market closes on Tuesday, February 21st. Analysts expect the company to announce earnings of $0.36 per share for the quarter. Parties that wish to listen to the company's conference call can do so using this link.
→ There’s A Reason People Are Skeptical About The Groundhog… (From Base Camp Trading)
SBRA stock opened at $13.22 on Tuesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.90 and a quick ratio of 2.90. The stock has a market capitalization of $3.05 billion, a P/E ratio of -165.25 and a beta of 1.29. The business has a 50-day moving average of $12.94 and a 200-day moving average of $13.53. Sabra Health Care REIT has a fifty-two week low of $11.44 and a fifty-two week high of $16.60.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 28th. Stockholders of record on Monday, February 13th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 10th. This represents a $1.20 annualized dividend and a dividend yield of 9.08%. Sabra Health Care REIT's dividend payout ratio is currently -1,500.00%.
Several brokerages recently commented on SBRA. JMP Securities cut Sabra Health Care REIT from an "outperform" rating to a "market perform" rating in a research report on Tuesday, December 13th. Bank of America cut Sabra Health Care REIT from a "neutral" rating to an "underperform" rating and reduced their price target for the company from $15.00 to $13.00 in a research report on Monday, November 14th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $15.00.
A number of hedge funds have recently made changes to their positions in SBRA. Balyasny Asset Management LLC boosted its stake in Sabra Health Care REIT by 6,220.5% in the 3rd quarter. Balyasny Asset Management LLC now owns 2,136,468 shares of the real estate investment trust's stock valued at $28,030,000 after purchasing an additional 2,102,666 shares during the period. State Street Corp boosted its position in shares of Sabra Health Care REIT by 18.1% in the first quarter. State Street Corp now owns 12,035,766 shares of the real estate investment trust's stock valued at $179,213,000 after acquiring an additional 1,840,939 shares during the period. Invesco Ltd. boosted its position in shares of Sabra Health Care REIT by 59.3% in the first quarter. Invesco Ltd. now owns 2,732,970 shares of the real estate investment trust's stock valued at $40,695,000 after acquiring an additional 1,017,252 shares during the period. Vanguard Group Inc. boosted its position in shares of Sabra Health Care REIT by 2.4% in the first quarter. Vanguard Group Inc. now owns 36,317,289 shares of the real estate investment trust's stock valued at $540,765,000 after acquiring an additional 859,548 shares during the period. Finally, Weiss Multi Strategy Advisers LLC boosted its position in shares of Sabra Health Care REIT by 230.8% in the first quarter. Weiss Multi Strategy Advisers LLC now owns 992,410 shares of the real estate investment trust's stock valued at $14,777,000 after acquiring an additional 692,438 shares during the period. 87.20% of the stock is owned by institutional investors and hedge funds.
Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
